The $50 copay, explained properly
Short answer: Under the Medicare GLP-1 Bridge, you pay a flat $50 for each one-month fill of Wegovy, Zepbound (KwikPen), or Foundayo — no deductible, same price all year. But because the program runs outside your Part D plan, the $50 never counts toward your out-of-pocket cap, and Extra Help doesn't reduce it.
Program facts last verified against CMS: August 20, 2026
What the $50 buys, and what it doesn't touch
The Bridge operates as its own nationwide program through a central processor administered by Humana — it is not a benefit inside your drug plan. That design is why no plan opt-in is needed and no deductible applies: your plan's cost-sharing rules simply never see these fills.
The same design produces the program's cost quirks. First, the $50 payments don't accumulate toward your Part D out-of-pocket cap (about $2,100 in 2026), so they never trigger the catastrophic phase where covered drugs become free. Second, Extra Help (the Low-Income Subsidy) doesn't apply — everyone pays the same $50. Third, the fills don't interact with your plan's formulary, tiers, or step-therapy rules at all. Fourth, and least known: fills under the Bridge are not eligible for the Medicare Prescription Payment Program, the option that lets you spread drug costs across the year in monthly installments. The $50 is due at the counter each time.
The annual math
Twelve months at $50 is $600 a year — for medications that run hundreds of dollars per month at retail. For most eligible people this is by far the cheapest access path to these drugs that has ever existed in Medicare. The chief caveat is time: the program ends December 31, 2027, so the earlier therapy starts, the more months of the $50 rate you can use.
It's worth knowing what the $50 is a fraction of. Under the demonstration's terms, participating manufacturers supply each monthly fill at a net price of $245, and the government covers the remainder beyond your copay. That number explains both why the program is generous and why its end date is real: the arrangement depends on negotiated manufacturer pricing and federal spending that were authorized for a fixed window, not on anything permanent in Part D.
Take the 2-minute eligibility check →
Common questions
Is the $50 per prescription or per month?
Per one-month fill of a covered drug. A year of continuous therapy costs $600.
Does the $50 count toward my Part D out-of-pocket cap?
No. The program sits outside Part D, so these payments never accumulate toward the annual cap.
Can my pharmacy charge me more than $50?
For a covered product with an approved prior authorization at a participating pharmacy, the program copay is $50. If you're quoted something different, ask the pharmacist to confirm the claim is processing under the Bridge — it routes through BIN 028918, PCN MEDDGLP1BR, not through your drug plan. The Zepbound KwikPen-only rule is the other common source of surprises.
Can I spread the $50 out through the Medicare Prescription Payment Program?
No. Drugs dispensed under the Bridge aren't eligible for that program, because it's a Part D feature and these fills sit outside Part D. The $50 is paid at each fill.
What does the program actually pay for the drug?
Participating manufacturers provide each monthly supply at a net price of $245 under the demonstration's terms. Your $50 is the beneficiary share of that.
Related
Program-fact sources: CMS — Medicare GLP-1 Bridge · KFF